This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Open-label Adjunctive Zonisamide for Bipolar Disorder

This study has been terminated.
Information provided by:
Elan Pharmaceuticals Identifier:
First received: October 8, 2002
Last updated: December 10, 2015
Last verified: December 2015
To study the safety and efficacy of zonisamide as adjunctive therapy for children and adolescents with bipolar I or II disorder.

Condition Intervention Phase
Bipolar Disorders Drug: zonisamide Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Elan Pharmaceuticals:

Estimated Enrollment: 20
Study Start Date: July 2002
Estimated Study Completion Date: July 2002

Ages Eligible for Study:   6 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
  • Bipolar I/II
  • Average intelligence
  • Taking at least one, but no more than two mood stabilizers
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information Identifier: NCT00047567     History of Changes
Other Study ID Numbers: ELN-345-509
Study First Received: October 8, 2002
Last Updated: December 10, 2015

Keywords provided by Elan Pharmaceuticals:

Additional relevant MeSH terms:
Bipolar Disorder
Bipolar and Related Disorders
Mental Disorders
Molecular Mechanisms of Pharmacological Action
Protective Agents
Physiological Effects of Drugs processed this record on September 19, 2017